PP
CLB icon

PDT Partners’s Core Laboratories CLB Stock Holding History

PDT Partners’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-69,211
Closed -$2.19M – 982
2022
Q1 		$2.19M Sell
69,211
-11,689
-14% -$328K 0.19% 151
2021
Q4 		$1.8M Hold
80,900
– – 0.14% 249
2021
Q3 		$2.25M Buy
80,900
+8,106
+11% +$247K 0.16% 234
2021
Q2 		$2.83M Buy
72,794
+6,294
+9% +$226K 0.19% 227
2021
Q1 		$1.92M Sell
66,500
-23,591
-26% -$806K 0.14% 271
2020
Q4 		$2.39M Sell
90,091
-35,307
-28% -$721K 0.16% 229
2020
Q3 		$1.91M Sell
125,398
-13,562
-10% -$284K 0.13% 220
2020
Q2 		$2.82M Buy
138,960
+119,260
+605% +$2.14M 0.19% 173
2020
Q1 		$204K Buy
19,700
+6,100
+45% +$171K 0.02% 560
2019
Q4 		$512K Buy
+13,600
New +$611K 0.03% 410
2017
Q2 		– Sell
-59,100
Closed -$6.83M – 521
2017
Q1 		$6.83M Buy
59,100
+6,600
+13% +$767K 0.36% 112
2016
Q4 		$6.3M Sell
52,500
-21,500
-29% -$2.38M 0.41% 65
2016
Q3 		$8.31M Buy
74,000
+59,100
+397% +$6.81M 0.49% 78
2016
Q2 		$1.85M Buy
+14,900
New +$1.8M 0.15% 204
2015
Q3 		– Sell
-48,725
Closed -$5.56M – 1305
2015
Q2 		$5.56M Sell
48,725
-49,151
-50% -$5.96M 0.15% 175
2015
Q1 		$10.2M Buy
97,876
+90,099
+1,159% +$9.6M 0.25% 89
2014
Q4 		$936K Buy
7,777
+1,600
+26% +$210K 0.09% 326
2014
Q3 		$904K Sell
6,177
-5,901
-49% -$911K 0.02% 715
2014
Q2 		$2.02M Buy
12,078
+5,903
+96% +$1.05M 0.05% 436
2014
Q1 		$1.23M Sell
6,175
-9,645
-61% -$1.82M 0.03% 612
2013
Q4 		$3.02M Buy
15,820
+4,031
+34% +$750K 0.36% 49
2013
Q3 		$2M Sell
11,789
-12,781
-52% -$1.98M 0.05% 492
2013
Q2 		$3.73M Buy
+24,570
New +$3.48M 0.09% 282

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

PDT Partners's CLB Position: Q2 2022 in Review

PDT Partners sold out of Core Laboratories (CLB) in Q2 2022, closing a stake of 69,211 shares — an estimated $2.19M sold.

PDT Partners first reported a position in CLB in Q2 2013 and held it in 23 quarters. The position peaked at $10.2M in Q1 2015. 175 funds tracked by Wall St. Rank hold CLB as of Q2 2022.

  • PDT Partners reported no remaining Core Laboratories position as of Q2 2022 after selling out during the quarter.
  • PDT Partners sold 69,211 Core Laboratories shares in Q2 2022, an estimated $2.19M.
  • PDT Partners first reported a position in Core Laboratories in Q2 2013 and held it in 23 quarters.
  • PDT Partners's Core Laboratories position peaked at $10.2M in Q1 2015.
  • 175 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2022.

Based on PDT Partners's 13F filing for Q2 2022, filed 15 Aug 2022.